title: MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript.
abstract: The P2X7 receptor regulates cell growth through mediation of apoptosis. P2X7 levels are lower in cancer epithelial cells than in normal cells, and previous studies showed that expression of P2X7 was regulated post-transcriptionally. The objective of the study was to understand regulation of P2X7 mRNA stability. Overexpression of a reporter containing the full-length human P2X7 3'-untranslated region (3'-UTR) or reporters containing parts of the 3'-UTR-P2X7 were associated with increased abundance of the construct in normal cells and decreased abundance in cancer epithelial cells. Sequences within the 3'-UTR-P2X7, which are putative target sites for the microRNAs, miR-186 (middle segment) and miR-150 (distal segment), decreased the abundance of the P2X7 transcript. Overexpression in cancer cells of mutated miR-186 and miR-150 target sites was associated with lower levels of the reporter genes. In normal cells overexpression of the mutated miR-186 target site was associated with marked increased concentration, but overexpression of the miR-150 target site reporters, wild-type and mutant, did not change over time. Levels of miR-186 and miR-150 were higher in cancer than in normal cells, and treatment with miR-186 and miR-150 inhibitors increased P2X7 mRNA. In human embryonic kidney-293 cells heterologously expressing the full-length 3'-UTR-P2X7 luciferase reporter, miR-186 and miR-150 inhibitors increased luciferase activity, whereas miR-186 and miR-150 mimics decreased luciferase activity after actinomycin D treatment. These data suggest that increased expression of miR-186 and miR-150 in cancer epithelial cells decreases P2X7 mRNA by activation of miR-186 and miR-150 instability target sites located at the 3'-UTR-P2X7.
authors.affiliation: Department of Reproductive Biology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
authors.forename: Lingyin
authors.initials: L
authors.lastname: Zhou
authors.forename: Xiaoping
authors.initials: X
authors.lastname: Qi
authors.forename: Judith A
authors.initials: JA
authors.lastname: Potashkin
authors.forename: Fadi W
authors.initials: FW
authors.lastname: Abdul-Karim
authors.forename: George I
authors.initials: GI
authors.lastname: Gorodeski
mesh_terms: D020413:3' Untranslated Regions; D017209:Apoptosis; D001483:Base Sequence; D001665:Binding Sites; D002584:Cervix Uteri / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D015536:Down-Regulation; D004717:Endometrium / Q000378:metabolism; D005260:Female; D006367:HeLa Cells; D006801:Humans; D035683:MicroRNAs / Q000235:genetics / Q000502:physiology*; D008954:Models, Biological; D008969:Molecular Sequence Data; D018048:Receptors, Purinergic P2 / Q000096:biosynthesis / Q000235:genetics*; D058486:Receptors, Purinergic P2X7
chemical_list: D020413:3' Untranslated Regions; D003609:Dactinomycin; D035683:MicroRNAs; D018048:Receptors, Purinergic P2; D058486:Receptors, Purinergic P2X7; C533097:MIR150, human; C533096:MIRN186 microRNA, human; C546468:P2RX7 protein, human